People have diverse microbial compositions that vary widely. It's unclear how these variations, both within an individual over time and between different individuals, impact health, disease onset, and progression. However, it's evident that shifts in the microbiome and its metabolites, and their interactions with the immune, endocrine, and nervous systems, are linked to numerous illnesses, including inflammatory bowel disease, cancer, and major depressive disorder. (Glibert et al., 2018).Dr. Paul Hammer, CEO & Founder of Biomes, is on a mission to [insert from company website]. In this episode, we discuss the Microbiome fingerprint and how we can leverage microbiome genomics to improve health outcomes.#ceo #podcast #clinicalresearch #Genomics #Microbiome #guthealth #PersonalizedMedicineFollow: Twitter: https://twitter.com/livialifesLinkedin: www.linkedin.com/in/livialifesAbout Me: Neuroute - copilot for clinical trials https://www.neuroute.co